MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517044706 A) filed by Lanova Medicines Limited, Shanghai, on May 8, for 'compounds compositions and methods.'
Inventor(s) include Li Runsheng; Huang Wentao; Liu Zhifang; and Zang Yingqin.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to anticancer compounds including but not limited to antibody drug conjugates using the same which compounds and ACDs thereof are suitable for the treatment of cancer."
The patent application was internationally filed on Oct. 09, 2023, under International application No.PCT/CN2023/123581.
Disclaimer: Curated by HT Syndication.
